beovu

Generic: brolucizumab

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name beovu
Generic Name brolucizumab
Labeler novartis pharmaceuticals corporation
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

brolucizumab 6 mg/.05mL

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-0827
Product ID 0078-0827_8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761125
Listing Expiration 2026-12-31
Marketing Start 2019-10-07

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00780827
Hyphenated Format 0078-0827

Supplemental Identifiers

RxCUI
2204920 2204925 2602276 2602279
UNII
XSZ53G39H5

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name beovu (source: ndc)
Generic Name brolucizumab (source: ndc)
Application Number BLA761125 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/.05mL
source: ndc
Packaging
  • 1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS
  • 1 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS
source: ndc

Packages (2)

0078-0827-60 1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS 0078-0827-98 1 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS

Ingredients (1)

brolucizumab (6 mg/.05mL)

Linked Drug Pages (1)

BEOVU ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6c", "openfda": {"unii": ["XSZ53G39H5"], "rxcui": ["2204920", "2204925", "2602276", "2602279"], "spl_set_id": ["5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (0078-0827-60)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "0078-0827-60", "marketing_start_date": "20220309"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (0078-0827-98)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "0078-0827-98", "marketing_start_date": "20220309"}], "brand_name": "BEOVU", "product_id": "0078-0827_8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6c", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0078-0827", "generic_name": "brolucizumab", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BEOVU", "active_ingredients": [{"name": "BROLUCIZUMAB", "strength": "6 mg/.05mL"}], "application_number": "BLA761125", "marketing_category": "BLA", "marketing_start_date": "20191007", "listing_expiration_date": "20261231"}